Technical Analysis for MYL - Mylan Inc.

Grade Last Price % Change Price Change
grade D 38.63 -0.62% -0.24
MYL closed down 0.62 percent on Thursday, June 21, 2018, on 46 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MYL trend table...

Date Alert Name Type % Chg
Jun 21 MACD Bearish Centerline Cross Bearish 0.00%
Jun 21 Stochastic Buy Signal Bullish 0.00%
Jun 21 Cup with Handle Other 0.00%
Jun 21 Calm After Storm Range Contraction 0.00%
Jun 21 Oversold Stochastic Weakness 0.00%
Jun 20 Death Cross Bearish -0.62%
Jun 20 Cup with Handle Other -0.62%
Jun 20 Calm After Storm Range Contraction -0.62%
Jun 20 Narrow Range Bar Range Contraction -0.62%
Jun 20 Oversold Stochastic Weakness -0.62%

Older signals for MYL ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mylan Inc. engages in the development, manufacture, marketing, licensing, and distribution of generic and branded generic pharmaceuticals, specialty pharmaceuticals, and active pharmaceutical ingredients (APIs) worldwide. It operates in two segments, Generics and Specialty. The Generics segment primarily develops, manufactures, sells, and distributes generic or branded generic pharmaceutical products in tablet, capsule, and injectable or transdermal patch forms, as well as API. It also focuses on developing APIs with non-infringing processes to partner with manufacturers. This segment serves proprietary and ethical pharmaceutical wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies. The Specialty segment manufactures and sells branded specialty injectable, nebulized, and transdermal products for life-threatening conditions. Its products include EpiPen Auto-Injector to treat severe allergic reactions; and Perforomist Inhalation Solution, a formoterol fumarate inhalation solution for the maintenance treatment of bronchoconstriction in chronic obstructive pulmonary disorder patients. This segment serves pharmaceutical wholesalers and distributors, pharmacies, and healthcare institutions. The company also manufactures and sells injectable products in various therapeutic areas for the hospital setting; supplies APIs for the manufacture of antiretroviral (ARV) drugs to treat HIV/AIDS; offers finished dosage form (FDF) products in the ARV market; and manufactures non-ARV FDF products, as well as focuses on developing, manufacturing, and commercializing dry powder inhaler delivery platform. Mylan Inc. has a strategic collaboration with Pfizer Japan Inc. The company was formerly known as Mylan Laboratories Inc. and changed its name to Mylan Inc. in October 2007. Mylan Inc. was founded in 1961 and is based in Canonsburg, Pennsylvania.
Is MYL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 47.82
52 Week Low 29.39
Average Volume 4,556,278
200-Day Moving Average 39.3466
50-Day Moving Average 39.274
20-Day Moving Average 39.706
10-Day Moving Average 39.998
Average True Range 1.0905
ADX 16.52
+DI 22.91
-DI 28.8
Chandelier Exit (Long, 3 ATRs ) 39.2285
Chandelier Exit (Short, 3 ATRs ) 41.2015
Upper Bollinger Band 42.055
Lower Bollinger Band 37.357
Percent B (%b) 0.27
BandWidth 11.831965
MACD Line -0.0409
MACD Signal Line 0.2029
MACD Histogram -0.2438
Fundamentals Value
Market Cap 20.72 Billion
Num Shares 536 Million
EPS 1.24
Price-to-Earnings (P/E) Ratio 31.15
Price-to-Sales 1.72
Price-to-Book 1.61
PEG Ratio 1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.67
Resistance 3 (R3) 39.68 39.35 39.49
Resistance 2 (R2) 39.35 39.09 39.34 39.43
Resistance 1 (R1) 38.99 38.92 38.83 38.98 39.38
Pivot Point 38.66 38.66 38.58 38.65 38.66
Support 1 (S1) 38.30 38.40 38.14 38.29 37.88
Support 2 (S2) 37.97 38.23 37.96 37.83
Support 3 (S3) 37.61 37.97 37.77
Support 4 (S4) 37.60